CEO SUMMARY: Rapid growth in what Medicare spent for molecular tests in recent years may lead federal investigators to increase scrutiny of fraudulent billing for clinical laboratory and molecular pathology tests, according to a lab consultant who has tracked such spending in recent years. Data show that Medicare spending for these tests rose sharply since 2017, and that in some Medicare […]
Medicare Pays 500% More for Molecular Test Claims
In some states between 2018 and 2019, Medicare paid 500% to 700% more for some genetic tests
- By Robert Michel
- > From the Volume XXVII, No. 14 - October 5, 2020 Issue
- Tags: clinical lab, clinical laboratories, Clinical Laboratory, clinical laboratory industry, clinical laboratory test, genetic testing, lab test, lab testing, lab testing services, laboratory industry, laboratory test, laboratory testing, laboratory tests, Medicare, Medicare payments, Pathology group, pathology groups, pathology lab
